Fundamental Analysis Stories
Are Tucows (USA Stocks:TCX) weak fundamental indicators contributing to the current slide?
few days ago at Macroaxis By Gabriel Shpitalnik |
Every cloud has a silver lining, but it seems Tucows Inc. (TCX) is still searching for its silver streak amidst a storm of weak fundamentals. The company, a key player in the Software - Infrastructure industry, has been experiencing a downtrend in its stock, which may be attributed to its underlying financial health. Tucows' net income from continuing operations reported a loss of $86.3 million, while its net income stood at a loss of $96.2 million. Continue Reading...
- TCX Tucows Inc
- Latest Can the Rally in Tucows Shares Continue - Yahoo Movies UK
- TCX 17.73 -0.19
- Low 17.5
- High 18.12
- Volume 57.3 K
- Alpha -0.82
- Beta 3.13
- Return On Equity -1.81
- Return On Asset -0.0503
- Profit Margin (0.28) %
- Operating Margin (0.18) %
- Current Valuation 551.16 M
- Shares Outstanding 10.94 M
- Shares Owned By Insiders 8.78 %
- Shares Owned By Institutions 79.38 %
- Number Of Shares Shorted 904.71 K
- Price To Earning 56.85 X
- Price To Book 6.52 X
- Price To Sales 0.58 X
- Revenue 339.34 M
- Gross Profit 107.44 M
- EBITDA 113.93 M
- Net Income (96.2 M)
- Cash And Equivalents 6.51 M
- Cash Per Share 0.60 X
- Total Debt 256.01 M
- Debt To Equity 2.14 %
- Current Ratio 0.36 X
- Book Value Per Share 0.91 X
- Cash Flow From Operations (10.87 M)
- Short Ratio 29.28 X
- Earnings Per Share (7.96) X
- Price To Earnings To Growth 1.15 X
- Target Price 150.01
- Beta 0.95
- Market Capitalization 195.99 M
- Total Asset 664.75 M
- Retained Earnings 55.9 M
- Working Capital (18.27 M)
- Current Asset 67.87 M
- Current Liabilities 78.26 M
- Z Score 1.62
- Net Asset 664.75 M
- Accumulation Distribution 1961.42
- Daily Balance Of Power (0.31)
- Rate Of Daily Change 0.99
- Day Median Price 17.81
- Day Typical Price 17.78
- Price Action Indicator (0.18)
- Period Momentum Indicator (0.19)
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Ellen Johnson
In the world of healthcare investing, Olink Holding AB (Ticker: OLK), a player in the Diagnostics & Research industry, continues to present a complex picture. Despite a robust net asset position of $476.29M and total current assets of $182.4M, the company's financial health is somewhat marred by a retained earnings loss of $75.9M and total operating expenses of $194.7M. The company's short and long-term debt total stands at a manageable $9.4M, while its net working capital is a healthy $146.4M.
six days ago at Macroaxis By Aina Ster |
We offer an investment recommendation to supplement the latest expert consensus on NeuBase Therapeutics. Our advanced recommendation engine uses a multidimensional algorithm to assess the company's growth potential, considering all available technical and fundamental data. The firm's dividend policy can hint at the stock's current value.
over a week ago at Macroaxis By Vlad Skutelnik |
The article illustrates the concept of Return on Investment (ROI), its significance, components, and the ways to calculate it. It explains how net profit and investment costs contribute to ROI calculation, the difference in interpreting ROI in short-term and long-term investments, the formula for basic ROI calculation, and the importance of incorporating time value of money (TVM) and risk factors in ROI calculations.
over a month ago at Macroaxis By Nico Santiago |
Our advice module can be utilized to supplement the investment recommendation for BankUnited, as provided by the average analyst sentiment. It scrutinizes the company's growth potential using available fundamental, technical, and market data. The dividends of this firm can offer insights into the current value of the stock.
over a month ago at Macroaxis By Vlad Skutelnik |
New Oriental Education's fundamentals show a promising picture with a healthy Return On Asset of 3.12% and a low Debt To Equity ratio of 0.15%. The company's net income from continuing operations stands at $235.4M, indicating a strong financial position. With a target price of $85.15, the stock's current price to earnings ratio of 113.17X suggests potential for further upside.
Main Ideas
New Oriental is currently valued at $71.49 per share, indicating a fair valuation with modest future projections.over a month ago at Macroaxis By Gabriel Shpitalnik |
Does CalciMedica Common (USA Stocks:CALC) have sound essential indicators based on the latest surge?
CalciMedica, a player in the Healthcare sector and Biotechnology industry, has been garnering attention this February. Despite a loss of $56.6M before tax and operating income at a loss of $55.9M, the company has a strong analyst consensus rating of 'Strong Buy'. With a market capitalization of $27.2M and a relatively low enterprise value of -$14.7M, there may be untapped potential in CalciMedica's common stock.
over a month ago at Macroaxis By Vlad Skutelnik |
Slow and steady wins the race, and RF Industries (NASDAQ: RFIL) seems to be following this mantra. The company, a key player in the Electronic Equipment, Instruments & Components industry, has been gradually ascending in the market, sparking speculation of a significant upswing. With a net asset value of $89.57M and net invested capital of $57.4M, RF Industries boasts a healthy balance sheet.
over two months ago at Macroaxis By Vlad Skutelnik |
ConAgra Foods (NYSE:CAG) has been demonstrating strong financial performance, with a reported EBITDA of $1.47B and a healthy operating income of $1.1B. The company's revenue per share stands at $25.67, further underlining its profitability. Despite a change in working capital reported at a loss of $816M, ConAgra has maintained a solid net asset base of $22.05B.
over two months ago at Macroaxis By Ellen Johnson |
Smart Global Holdings has an Efficiency Ratio, also known as the Sharpe Ratio, of -0.0155. This indicates that the company has had a return of -0.0155% per unit of risk over the last three months. When assessing the risk of any stock, we consider both systematic and unsystematic factors of the business, including all available market data and technical indicators.
over two months ago at Macroaxis By Ellen Johnson |